Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 12.5.2022N.V. Organon (ORG-NL)85810Lerivon 30 mg (tbl flm 20x30 mg (blis.PVC/Al))12.5.2022R
 12.5.2022Opella Healthcare Slovakia s.r.o. (OPL)26797Muconasal plus (aer nao 1x10 ml (fľ.skl.))12.5.2022O
 12.5.2022ratiopharm GmbH (RAT)85145Ratiograstim 30 MIU/0,5 ml injekčný alebo infúzny roztok (sol ijf 5x0,5 ml/300 µg (30 MIU) (striek.skl.napln. s bezp.zar.))20.5.2022O
 12.5.2022Zentiva, k.s. (ZNT-1)4885BPriamlo 4 mg/5 mg (tbl 30x4 mg/5 mg (blis.OPA/Al/PVC/Al))12.5.2022R
 12.5.2022Zentiva, k.s. (ZNT-1)4886BPriamlo 4 mg/5 mg (tbl 90x4 mg/5 mg (blis.OPA/Al/PVC/Al))31.5.2022R
 12.5.2022Novartis Europharm Limited (NEH-IE)3250DExelon 13,3 mg/24 h transdermálna náplasť (emp tdm 30x13,3 mg/24 hodín (vre.pap.PET/PE/Al/PA))10.5.2022O
 12.5.2022CHEPLAPHARM Arzneimittel GmbH (CEP-1)90760Ebrantil 30 (cps pld 50x30 mg (fľ.HDPE))12.5.2022R
 12.5.2022ratiopharm GmbH (RAT)57291Perindopril ratiopharm 8 mg (tbl 90x8 mg (blis.PVC/PE/PVDC/Al))27.5.2022R
 11.5.2022BB Pharma a.s. (BBP-CZ-1)8044ABITAMMON 375 (tbl obd 2x7x375 mg (blis.Al/OPA/Al/PVC))12.5.2022O
 11.5.2022GlaxoSmithKline Biologicals S.A. (GAG)69867Synflorix injekčná suspenzia v naplnenej injekčnej striekačke (sus inj 10x0,5 ml (10 napl.inj.striek. + 10 ihiel))11.5.2022O
 11.5.2022GlaxoSmithKline Vaccines S.r.I. (GAG-IT)4431ABexsero injekčná suspenzia v naplnenej injekčnej striekačke, Vakcína proti meningokokom skupiny B (rDNA, zložková, adsorbovaná) (sus inj 1x0,5 ml (striek.inj.napl.skl.+ihla))11.5.2022O
 11.5.2022JSC "Grindeks" (JSG)10980Sonlax 7,5 mg filmom obalené tablety (tbl flm 20(2x10)x7,5 mg (blis.PVC/PVDC/Al))11.5.2022R
 11.5.2022Actavis Group PTC ehf. (ACT-5)01590Telmisartan Actavis 40 mg tablety (tbl 90x40 mg (blis.Al/Al))30.5.2022R
 10.5.2022Viatris Limited (VIM)58658Irinotecan Mylan 20 mg/ ml (con inf 1x5 ml/100 mg (liek.inj.skl.hnedá))11.5.2022R
 10.5.2022Sanofi Winthrop Industrie (SWI-11)6388DPraluent 300 mg injekčný roztok naplnený v injekčnom pere (sol inj 1x2 ml/300 mg (pero inj.skl.napl. bez akt.tlačidla))16.5.2022R

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)